GV led a $58.5 million investment to launch Verve Therapeutics, a new biotech focused on developing therapies that edit the human genome to treat heart diseases.
from NDTV Gadgets - Latest http://bit.ly/2DTO11A
Subscribe to:
Post Comments (Atom)
-
In a short span of time, Nothing has come a long way, and it now actually stands for something. The company makes good mid-range and upper m...
-
Rocket Lab has confirmed that its reusable Neutron rocket is set for its first launch in the latter half of 2025. The announcement was made ...
-
Just Eat Takeaway said on Thursday its proposed $6 billion takeover of Grubhub to create a trans-Atlantic giant would give it the upper hand...
No comments:
Post a Comment